PROFOUND MEDICAL CORP. Amortization of Intangible Assets
PROFOUND MEDICAL CORP. (PROF) reported Amortization of Intangible Assets of $16.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- PROFOUND MEDICAL CORP. amortization of intangible assets for the quarter ending 2026-06-30 was $9.00K, a 76.92% decline year-over-year.
- PROFOUND MEDICAL CORP. amortization of intangible assets for the quarter ending 2026-03-31 was $7.00K, a 85.11% decline year-over-year.
- PROFOUND MEDICAL CORP. amortization of intangible assets for the quarter ending 2025-12-31 was $47.00K, a 39.74% decline year-over-year.
- PROFOUND MEDICAL CORP. amortization of intangible assets for the quarter ending 2025-09-30 was $54.00K, a 8.00% increase year-over-year.
- PROFOUND MEDICAL CORP. amortization of intangible assets for fiscal 2024 was $229.00K, a 13.37% increase from fiscal 2023.
- PROFOUND MEDICAL CORP. amortization of intangible assets for fiscal 2023 was $202.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $16.00K 10-Q · filed 2026-08-06 | $63.00K derived: sum of 3 quarters · filed 2026-08-06 | $117.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $7.00K 10-Q · filed 2026-05-07 | $54.00K derived: sum of 2 quarters · filed 2026-08-06 | $108.00K derived: sum of 3 quarters · filed 2026-08-06 | $147.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $47.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-06 | $101.00K derived: sum of 2 quarters · filed 2026-08-06 | $140.00K derived: sum of 3 quarters · filed 2026-08-06 | $187.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $93.00K derived: sum of 2 quarters · filed 2026-08-06 | $140.00K 10-Q · filed 2025-11-13 | $218.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $86.00K 10-Q · filed 2026-08-06 | $164.00K derived: sum of 3 quarters · filed 2026-08-06 | $214.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $47.00K 10-Q · filed 2026-05-07 | $125.00K derived: sum of 2 quarters · filed 2026-05-07 | $175.00K derived: sum of 3 quarters · filed 2026-05-07 | $225.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $128.00K derived: sum of 2 quarters · filed 2026-03-05 | $178.00K derived: sum of 3 quarters · filed 2026-03-05 | $229.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $100.00K derived: sum of 2 quarters · filed 2025-11-13 | $151.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $101.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $51.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $202.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |